Navigation Links
Finally, The First Ever Treatment for Drug-Resistant HIV

ding to research results.

"In Phase 3 clinical trials of TMC-114, the majority of patients receiving the drug did very well with relatively few side effects," Mitsuya said. "Those patients showed a significant increase in their CD4 cell counts. Many of those patients have been treated for a year or more and have shown no signs of developing a significant resistance to the drug."

Ghosh is now expanding on his design, making alterations to the original molecule aimed at making even more effective treatments. "The most recent protease inhibitors we created are exceedingly potent," he said. Ghosh's work has opened the door to a new path for antiretroviral therapy.

"Earlier, researchers were unsure of how to deal with drug-resistant viruses," he said. "Problems that arose with treatments developed in the 1990s were disheartening. There was no concept on the horizon. We created a conceptually new class of protease inhibitors to combat drug resistance. That has renewed excitement in antiretroviral treatment and provided a direction for the future." These new protease inhibitors are beneficial for reasons beyond their potency and enduring effectiveness, Ghosh said.

"Because they are synthetic, lab-created materials, they are amenable to cost-effective mass production. Keeping costs down greatly increases the accessibility of the drugs to Third World countries where the epidemic is worst."

The design, synthesis and evaluation of these new protease inhibitors will be detailed in a paper in the Aug. 24 issue of the Journal of Medicinal Chemistry and is currently available on the journal's Web site.

Irene Weber of Georgia State University, Eric Walters of Rosalind Franklin University of Medicine and Mitsuya co-authored the papers with Ghosh. Mitsuya characterized the molecules' effectiveness and Walters and Weber performed the crystallography that provided images of the molecules' structures.
<
'"/>




Page: 1 2 3 4

Related medicine news :

1. Finally, light at the end of the tunnel for those suffering tunnel vision
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
4. First human clone is near
5. First Artificial Heart patient has Major setback
6. First head-to-head trials of once weekly Fosamax and Actonel therapies
7. WHO Declares Vietnam First Country to Control SARS
8. Russia Reports First SARS Case
9. Hope for First New Melanoma Treatment in Decades
10. First global SARS meet opens
11. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Finally The First Ever Treatment for Drug Resistant HIV

(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Sir Fazle ... annual World Food Prize today. Sir Fazle has been recognised for his outstanding contribution ... , Ambassador Ken Quinn, President of the World Food Prize Foundation, announced this ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... announced that they will welcome four new members to their industry leading Scientific ...
(Date:7/1/2015)... ... July 01, 2015 , ... DIC Corporation today announced the ... natural blue food coloring. Construction of the plant, which is located on the ... began in May 2014. After commissioning, commercial production is expected to begin in ...
(Date:7/1/2015)... ... July 01, 2015 , ... OncLive® ... Hospital Corporation of America (HCA), as it further expands its Strategic Alliance Partnership ... , With this new partnership, OncLive’s editorial and marketing teams will collaborate with ...
(Date:7/1/2015)... ... ... The 28th annual Charity Horse Show hosted by the Mid-South Horse Show Association ... Pugh Bourne Park, 343 Oakfield Road. The event will again benefit Youth Town. , ... silent auction and concessions. , Horses and riders from around the country will participate ...
Breaking Medicine News(10 mins):Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3
... taken gigantic proportions not only in the animal world but human ... wanting to visit // countries with bird flu like China, Vietnam, ... moment the unanimous voice is to take the plunge as bird ... to worry., ,The infection in humans is due to close ...
... to India for the sake of low priced cosmetic ... waistline, rhinoplasty, and breast improvements are very expensive. // ... UK every year. ,Recent figures released ... that breast enlargement topped the list of cosmetic operations ...
... beset with administrative problems, experienced another upheaval. In a ... // Dr. Hart, the Director of the program for ... Dr Hart will still continue as a full-time surgeon ... ,The UC San Diego, disappointed with the manner in ...
... A domino transplant surgery was conducted through which 3-month-old Jason ... week old baby received a heart // transplant in Ohio. ... passed away, and its organs were compatible to the two ... ,The dead child’s heart and lungs were transplanted to ...
... Canada has been warned of fines by the Government if ... Copeman Healthcare intends to establish clinics in Ottawa, Toronto, and ... charging a joining fee of $1,200, and another $2,300 towards ... ,The medicare law of the state says a fine of ...
... President George W. Bush as called for complete banning on ... as asked to reduce the medical // liability system; the ... among the American people which has reduced the number of ... talk as urged the congress to approve a complete ban ...
Cached Medicine News:Health News:More People Come To India For Cosmetic Surgery 2
(Date:7/1/2015)... DUBLIN , June 24, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/34xqr7/2015_new ) has announced the addition of ... Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, ... their offering. 2015 New Frontiers ... Business Challenges, Emerging Technologies, Competitive Landscape is ...
(Date:7/1/2015)... , June 24, 2015 ... announced the addition of the "2015 Strategies ... their offering. This new 175-page report ... segments, including diabetes (strips and meters), pregnancy, ovulation, ... size, growth, regulatory requirements, technologies, and competitive profiles. ...
(Date:7/1/2015)... 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ... and commercialization of proprietary compounded drug formulations, today ... stock market closing bell on Thursday, July 2, ... its Go Dropless™ campaign since its launch in ... performed annually in the U.S. and more than ...
Breaking Medicine Technology:2015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 22015 Strategies in the Home/Self Testing Market 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... The Auto Suture™ VERSAPORT™ PLUS RPF trocar ... mm long, 5 mm-11 mm, 5 mm-12 mm, ... sleeve and shield. , ,The VERSAPORT™ PLUS ... a spring-loaded shield. Upon entry into a free ...
The SURGINEEDLE™ is a veress type needle that is used to insufflate the abdomen to create pneumoperitoneum....
... The complete line of Surgical Access ...unlike ... ,The OnePort™ trocar system is actually four ... versatile, operationally flexible and clinically adaptive to ... options in disposability and bladed or dilating ...
... The complete line of Surgical Access ...unlike ... ,The OnePort™ trocar system is actually four ... versatile, operationally flexible and clinically adaptive to ... options in disposability and bladed or dilating ...
Medicine Products: